IltefatHHamzaviMD

Dermatology • Canton, MI

Dermatologic Surgery

Physician Hamzavi/Dermatology specialists and Henry Ford Hospital

Join to view full profile

Dr. Hamzavi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hamzavi's full profile

Already have an account?

Office
361 N Canton Center Rd
Canton, MI 48187
Phone+1 734-495-1506

Fax+1 734-495-1780

Summary

Dr. Iltefat Hamzavi is a dermatologist in Canton,Detroit and Fort Gratiot, MI and is affiliated with multiple hospitals in the area, including Henry Ford Hospital,McLaren Port Huron, St. Joseph Mercy Ann Arbor, Lake Huron Medical Center, and Beaumont Hospital, Wayne. He received his medical degree from University of Michigan Medical School and has been in practice 21 years. He is experienced in general dermatology, photomedicine,Vitiligo,Hidradenitis Suppurativa, and complex medical dermatology.

Education & Training

University of British ColumbiaFellowship, 2000 - 2001
Wayne State University School of MedicineResidency, Dermatology, 1997 - 2000
Trinity Health Ann Arbor HospitalInternship, Internal Medicine, 1996 - 1997
University of Michigan Medical SchoolClass of 1996

Certifications & Licensure

MI State Medical License 2000 - 2025
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Best Doctors Best Doctors
Top Docs Hours magazine
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FAAD) American Academy of Dermatology
Fellow (FASDS) American Society for Dermatologic Surgery
Join now to see all

Clinical Trials

Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo Start of enrollment: 2006 Jan 01
Completed
Not Applicable
Impact of Long Wavelength Ultraviolet (UVA) and Visible Light on Melanocompetent Skin Start of enrollment: 2007 May 01
Completed
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa Start of enrollment: 2007 Jun 01
Completed
Not Applicable
Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy Start of enrollment: 2008 May 01
Completed
NdYag Laser for Acne Keloidalis Nuchae Start of enrollment: 2008 Sep 01
Unknown status
Not Applicable
Vitiligo Skin Transplantation Start of enrollment: 2009 Jan 01
Completed
Phase 3
Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa Start of enrollment: 2010 Feb 01
Completed
Not Applicable
Case-control Study on Matrix Metalloproteinase Levels in Tissue in Patients With Keloid Scar Start of enrollment: 2010 Feb 01
Completed
Not Applicable
Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia Start of enrollment: 2009 Feb 01
Completed
Treatment of Vitiligo With Low-energy Visible Light Laser Start of enrollment: 2010 Oct 01
Terminated
Not Applicable
NB-UVB and PUVA Vitiligo Study Start of enrollment: 2013 Mar 01
Completed
Phase 4
Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED) Start of enrollment: 2012 May 01
Withdrawn
Not Applicable
An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa. Start of enrollment: 2013 Jan 05
Completed
Not Applicable
Comparative Study Using Dermabrasion vs CO2 Laser & Collagen Dressing vs Vaseline Gauze in MKTP Start of enrollment: 2014 Jan 01
Unknown status
Not Applicable
Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing Start of enrollment: 2015 Jan 14
Completed
Not Applicable
An In Vivo Model for Postinflammatory Hyperpigmentation Start of enrollment: 2016 Feb 14
Completed
Not Applicable
The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects Start of enrollment: 2018 Mar 13
Completed
Not Applicable
Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects Start of enrollment: 2019 Nov 05
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Concurrent management of vitiligo and acquired disorders of hyperpigmentation: a comprehensive literature review and current practice gaps.
Brittany N Lane, Iltefat H Hamzavi, Henry W Lim, Michelle Rodrigues, Nada Elbuluk
International Journal of Dermatology. 2025-01-16
Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis.
Nicole Trupiano, Kelly Young, Harika Echuri, Jalal Maghfour, Lauren A V Orenstein
The Journal of Dermatology. 2025-01-15
High-throughput proteomics identifies inflammatory proteins associated with disease severity and genetic ancestry in patients with hidradenitis suppurativa.
Peter M Dimitrion, Rachel Krevh, Jesse Veenstra, James Ge, Aamir Siddiqui
The British Journal of Dermatology. 2025-01-08

Journal Articles

Surgical Interventions for Patients with Vitiligo
Iltefat Hamzavi, MD, JAMA Dermatology
Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum
Haley B Naik, Iltefat H Hamzavi, Jennifer L Hsiao, JAMA Dermatology

Lectures

Advanced Management Strategies for Hidradenitis Suppurativa
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019

Authored Content

Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and PostpartumMay 2020

Press Mentions

Hottest Topics of the 2023 AAD Annual MeetingMarch 27th, 2023
Ruxolitinib Cream Meets Primary Endpoints in Phase 3 Vitiligo TrialOctober 5th, 2021
UV-C Light Effectively Kills COVID-19 Virus on N95sSeptember 24th, 2020
Join now to see all